Upcoming Events Archives

AMP Europe

2026-04-14T06:54:35-07:00April 14th, 2026|Conferences, Upcoming Events|

EHA

2026-04-14T06:53:46-07:00April 14th, 2026|Conferences, Upcoming Events|

The 66th Annual Meeting of the Japanese Society of Lymphoma Research

2026-04-14T06:52:37-07:00April 14th, 2026|Conferences, Upcoming Events|

Festival of Genomics, Biodata & AI

2026-04-14T06:51:51-07:00April 14th, 2026|Conferences, Upcoming Events|

ASCO

2026-04-14T06:50:53-07:00April 14th, 2026|Conferences, Upcoming Events|

16th JSH International Symposium

2026-04-14T06:49:56-07:00April 14th, 2026|Conferences, Upcoming Events|

TRI-CON 2026

2026-04-14T06:49:11-07:00April 14th, 2026|Conferences, Upcoming Events|

2nd EHA-SWG Scientific Meeting on MDS/MPN/AML: Commonalities and Differences of Myeloid Neoplasms

2026-04-14T06:47:51-07:00April 14th, 2026|Conferences, Upcoming Events|

BSH 2026

2026-04-14T06:46:29-07:00April 14th, 2026|Conferences, Upcoming Events|

AACR

2026-04-14T06:45:05-07:00April 14th, 2026|Conferences, Upcoming Events|

115th The Annual meeting of the Japanese Society of Pathology

2026-04-14T06:43:51-07:00April 14th, 2026|Conferences, Upcoming Events|

Invivoscribe to Participate in Virtual ASCO 2020

2020-05-27T18:13:43-07:00May 15th, 2020|Events, Upcoming Events|

Invivoscribe to Exhibit at 25th EHA Annual Congress

2020-05-27T18:11:58-07:00May 15th, 2020|Events, Upcoming Events|

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Lymphoma

Browse our comprehensive menu of product & testing services.

Myeloma

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia

Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin Lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing

Evaluation of Next-Generation Sequencing Versus Next-Generation Flow Cytometry for Minimal Residual Disease Detection in Chinese Patients with Multiple Myeloma

Lymphoma

Browse our comprehensive menu of product & testing services.

Myeloma

AMP Europe

EHA

The 66th Annual Meeting of the Japanese Society of Lymphoma Research

Festival of Genomics, Biodata & AI

ASCO

16th JSH International Symposium

TRI-CON 2026

2nd EHA-SWG Scientific Meeting on MDS/MPN/AML: Commonalities and Differences of Myeloid Neoplasms

BSH 2026

AACR

115th The Annual meeting of the Japanese Society of Pathology

Invivoscribe to Participate in Virtual ASCO 2020

Invivoscribe to Exhibit at 25th EHA Annual Congress

The Laboratory for Personalized Molecular Medicine® (LabPMM®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Lymphoma

Browse our comprehensive menu of product & testing services.

Myeloma

A proven strategy to accelerate drug approvals

Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

We take pride in expanding the science that bridges personalized medicine with quality healthcare.

Personalized Molecular Medicine® is use of genomics and patient specific information to identify optimal treatment for each patient.

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia

Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia

Assessment of Bone Marrow Involvement in B-Cell non-Hodgkin Lymphoma Using Immunoglobulin Gene Rearrangement Analysis with Next-Generation Sequencing

Evaluation of Next-Generation Sequencing Versus Next-Generation Flow Cytometry for Minimal Residual Disease Detection in Chinese Patients with Multiple Myeloma

Lymphoma

Browse our comprehensive menu of product & testing services.

Myeloma

The Laboratory for Personalized Molecular Medicine^® (LabPMM^®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

Personalized Molecular Medicine^® is use of genomics and patient specific information to identify optimal treatment for each patient.